Click for best price
Biopharmaceutical Vaccines Market Size, Share 2022
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
This report contains market size and forecasts of Biopharmaceutical and Vaccines in Global, including the following market information:
Global Biopharmaceutical and Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biopharmaceutical and Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Biopharmaceutical Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceutical and Vaccines include Novartis, Pfizer, Sanofi, Roche, Abbott, Biogen Idec, Regeneron Pharmaceuticals, Alexion Pharmaceuticals and Johnson and Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceutical and Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceutical and Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biopharmaceutical and Vaccines Market Segment Percentages, by Type, 2021 (%)
Biopharmaceutical
Vaccine Production
Global Biopharmaceutical and Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biopharmaceutical and Vaccines Market Segment Percentages, by Application, 2021 (%)
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others
Global Biopharmaceutical and Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biopharmaceutical and Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biopharmaceutical and Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biopharmaceutical and Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Sanofi
Roche
Abbott
Biogen Idec
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
Boehringer Ingelheim
Rentschler
| Report Attributes |
Report Details |
| Report Title |
Biopharmaceutical and Vaccines Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biopharmaceutical and Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biopharmaceutical and Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biopharmaceutical and Vaccines Overall Market Size
2.1 Global Biopharmaceutical and Vaccines Market Size: 2021 VS 2028
2.2 Global Biopharmaceutical and Vaccines Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biopharmaceutical and Vaccines Players in Global Market
3.2 Top Global Biopharmaceutical and Vaccines Companies Ranked by Revenue
3.3 Global Biopharmaceutical and Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceutical and Vaccines Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biopharmaceutical and Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceutical and Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Biopharmaceutical and Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Biopharmaceutical and Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biopharmaceutical and Vaccines Market Size Markets, 2021 & 2028
4.1.2 Biopharmaceutical
4.1.3 Vaccine Production
4.2 By Type - Global Biopharmaceutical and Vaccines Revenue & Forecasts
4.2.1 By Type - Global Biopharmaceutical and Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Biopharmaceutical and Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biopharmaceutical and Vaccines Market Size, 2021 & 2028
5.1.2 Pharmaceuticals Industry
5.1.3 Clinical Diagnosis
5.1.4 Scientific Research
5.1.5 Others
5.2 By Application - Global Biopharmaceutical and Vaccines Revenue & Forecasts
5.2.1 By Application - Global Biopharmaceutical and Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Biopharmaceutical and Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biopharmaceutical and Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Biopharmaceutical and Vaccines Revenue & Forecasts
6.2.1 By Region - Global Biopharmaceutical and Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Biopharmaceutical and Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biopharmaceutical and Vaccines Revenue, 2017-2028
6.3.2 US Biopharmaceutical and Vaccines Market Size, 2017-2028
6.3.3 Canada Biopharmaceutical and Vaccines Market Size, 2017-2028
6.3.4 Mexico Biopharmaceutical and Vaccines Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biopharmaceutical and Vaccines Revenue, 2017-2028
6.4.2 Germany Biopharmaceutical and Vaccines Market Size, 2017-2028
6.4.3 France Biopharmaceutical and Vaccines Market Size, 2017-2028
6.4.4 U.K. Biopharmaceutical and Vaccines Market Size, 2017-2028
6.4.5 Italy Biopharmaceutical and Vaccines Market Size, 2017-2028
6.4.6 Russia Biopharmaceutical and Vaccines Market Size, 2017-2028
6.4.7 Nordic Countries Biopharmaceutical and Vaccines Market Size, 2017-2028
6.4.8 Benelux Biopharmaceutical and Vaccines Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biopharmaceutical and Vaccines Revenue, 2017-2028
6.5.2 China Biopharmaceutical and Vaccines Market Size, 2017-2028
6.5.3 Japan Biopharmaceutical and Vaccines Market Size, 2017-2028
6.5.4 South Korea Biopharmaceutical and Vaccines Market Size, 2017-2028
6.5.5 Southeast Asia Biopharmaceutical and Vaccines Market Size, 2017-2028
6.5.6 India Biopharmaceutical and Vaccines Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biopharmaceutical and Vaccines Revenue, 2017-2028
6.6.2 Brazil Biopharmaceutical and Vaccines Market Size, 2017-2028
6.6.3 Argentina Biopharmaceutical and Vaccines Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biopharmaceutical and Vaccines Revenue, 2017-2028
6.7.2 Turkey Biopharmaceutical and Vaccines Market Size, 2017-2028
6.7.3 Israel Biopharmaceutical and Vaccines Market Size, 2017-2028
6.7.4 Saudi Arabia Biopharmaceutical and Vaccines Market Size, 2017-2028
6.7.5 UAE Biopharmaceutical and Vaccines Market Size, 2017-2028
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Biopharmaceutical and Vaccines Major Product Offerings
7.1.4 Novartis Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.1.5 Novartis Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Biopharmaceutical and Vaccines Major Product Offerings
7.2.4 Pfizer Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Biopharmaceutical and Vaccines Major Product Offerings
7.3.4 Sanofi Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Biopharmaceutical and Vaccines Major Product Offerings
7.4.4 Roche Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.4.5 Roche Key News
7.5 Abbott
7.5.1 Abbott Corporate Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Biopharmaceutical and Vaccines Major Product Offerings
7.5.4 Abbott Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.5.5 Abbott Key News
7.6 Biogen Idec
7.6.1 Biogen Idec Corporate Summary
7.6.2 Biogen Idec Business Overview
7.6.3 Biogen Idec Biopharmaceutical and Vaccines Major Product Offerings
7.6.4 Biogen Idec Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.6.5 Biogen Idec Key News
7.7 Regeneron Pharmaceuticals
7.7.1 Regeneron Pharmaceuticals Corporate Summary
7.7.2 Regeneron Pharmaceuticals Business Overview
7.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Major Product Offerings
7.7.4 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.7.5 Regeneron Pharmaceuticals Key News
7.8 Alexion Pharmaceuticals
7.8.1 Alexion Pharmaceuticals Corporate Summary
7.8.2 Alexion Pharmaceuticals Business Overview
7.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Major Product Offerings
7.8.4 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.8.5 Alexion Pharmaceuticals Key News
7.9 Johnson and Johnson
7.9.1 Johnson and Johnson Corporate Summary
7.9.2 Johnson and Johnson Business Overview
7.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Major Product Offerings
7.9.4 Johnson and Johnson Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.9.5 Johnson and Johnson Key News
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Corporate Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Major Product Offerings
7.10.4 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.10.5 GlaxoSmithKline Key News
7.11 Merck
7.11.1 Merck Corporate Summary
7.11.2 Merck Business Overview
7.11.3 Merck Biopharmaceutical and Vaccines Major Product Offerings
7.11.4 Merck Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.11.5 Merck Key News
7.12 Lonza
7.12.1 Lonza Corporate Summary
7.12.2 Lonza Business Overview
7.12.3 Lonza Biopharmaceutical and Vaccines Major Product Offerings
7.12.4 Lonza Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.12.5 Lonza Key News
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Corporate Summary
7.13.2 Boehringer Ingelheim Business Overview
7.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Major Product Offerings
7.13.4 Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.13.5 Boehringer Ingelheim Key News
7.14 Rentschler
7.14.1 Rentschler Corporate Summary
7.14.2 Rentschler Business Overview
7.14.3 Rentschler Biopharmaceutical and Vaccines Major Product Offerings
7.14.4 Rentschler Biopharmaceutical and Vaccines Revenue in Global Market (2017-2022)
7.14.5 Rentschler Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biopharmaceutical and Vaccines Market Opportunities & Trends in Global Market
Table 2. Biopharmaceutical and Vaccines Market Drivers in Global Market
Table 3. Biopharmaceutical and Vaccines Market Restraints in Global Market
Table 4. Key Players of Biopharmaceutical and Vaccines in Global Market
Table 5. Top Biopharmaceutical and Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biopharmaceutical and Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biopharmaceutical and Vaccines Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biopharmaceutical and Vaccines Product Type
Table 9. List of Global Tier 1 Biopharmaceutical and Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceutical and Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biopharmaceutical and Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biopharmaceutical and Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biopharmaceutical and Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biopharmaceutical and Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biopharmaceutical and Vaccines Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biopharmaceutical and Vaccines Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Biopharmaceutical and Vaccines Product Offerings
Table 32. Novartis Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Biopharmaceutical and Vaccines Product Offerings
Table 35. Pfizer Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Biopharmaceutical and Vaccines Product Offerings
Table 38. Sanofi Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Biopharmaceutical and Vaccines Product Offerings
Table 41. Roche Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Corporate Summary
Table 43. Abbott Biopharmaceutical and Vaccines Product Offerings
Table 44. Abbott Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 45. Biogen Idec Corporate Summary
Table 46. Biogen Idec Biopharmaceutical and Vaccines Product Offerings
Table 47. Biogen Idec Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 48. Regeneron Pharmaceuticals Corporate Summary
Table 49. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product Offerings
Table 50. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 51. Alexion Pharmaceuticals Corporate Summary
Table 52. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product Offerings
Table 53. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 54. Johnson and Johnson Corporate Summary
Table 55. Johnson and Johnson Biopharmaceutical and Vaccines Product Offerings
Table 56. Johnson and Johnson Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline Corporate Summary
Table 58. GlaxoSmithKline Biopharmaceutical and Vaccines Product Offerings
Table 59. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 60. Merck Corporate Summary
Table 61. Merck Biopharmaceutical and Vaccines Product Offerings
Table 62. Merck Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 63. Lonza Corporate Summary
Table 64. Lonza Biopharmaceutical and Vaccines Product Offerings
Table 65. Lonza Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 66. Boehringer Ingelheim Corporate Summary
Table 67. Boehringer Ingelheim Biopharmaceutical and Vaccines Product Offerings
Table 68. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
Table 69. Rentschler Corporate Summary
Table 70. Rentschler Biopharmaceutical and Vaccines Product Offerings
Table 71. Rentschler Biopharmaceutical and Vaccines Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biopharmaceutical and Vaccines Segment by Type in 2021
Figure 2. Biopharmaceutical and Vaccines Segment by Application in 2021
Figure 3. Global Biopharmaceutical and Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biopharmaceutical and Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biopharmaceutical and Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biopharmaceutical and Vaccines Revenue in 2021
Figure 8. By Type - Global Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
Figure 12. US Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
Figure 16. Germany Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 17. France Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
Figure 24. China Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. India Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
Figure 30. Brazil Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biopharmaceutical and Vaccines Revenue Market Share, 2017-2028
Figure 33. Turkey Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biogen Idec Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Johnson and Johnson Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Lonza Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Rentschler Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
